Advertisement

Topics

Vivus Company Profile

22:54 EDT 21st September 2017 | BioPortfolio

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annually. VIVUS has three products that are positioned to enter Phase 3 clinical trials and one product currently under NDA review by the FDA. The investigational pipeline includes: Qnexa™, for which a Phase 2 study has been completed for the treatment of obesity; Testosterone MDTS®, for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist™, for which a Phase 3 study has been completed and an NDA submitted for the treatment of menopausal symptoms; avanafil, for which a Phase 2 study has been completed for the treatment of erectile dysfunction (ED); and, MUSE®, which is approved and currently on the market for the treatment of ED.

Location

1172 Castro Street
Mountain View
CA
94040
United States of America

Contact

Phone: 650 934 5200


News Articles [21 Associated News Articles listed on BioPortfolio]

Vivus, Dr. Reddy's settle patent litigation relating to Qsymia

Vivus Inc. and Dr. Reddy's Laboratories Ltd. have settled patent litigation surrounding Vivus' weight management product Qsymia (phentermine and topiramate extended-release capsules). The litigation h...

EMA grants orphan status to VIVUS' PAH drug

VIVUS' tacrolimus was granted orphan drug designation by the European Medicines Agency as a treatment for patients with pulmo -More- 

VIVUS to Present at 2017 Wells Fargo Healthcare Conference on September 7, 2017

CAMPBELL, CA--(Marketwired - August 22, 2017) - VIVUS,Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies focus...

Topiramate Exposure and Fetal Outcomes in Migraine Patients to Be Presented at the 136th ANA Annual Meeting

MOUNTAIN VIEW, Calif., Sept. 26, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that a poster authored by Dr. Mark W. Green, Director of the Center for Headache and Pain Medicine and ...

Vivid Potential Victory With Vivus, Inc. Convertible Bonds

Thomas B. King Joins VIVUS' Board of Directors

CAMPBELL, CA--(Marketwired - May 24, 2017) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), announced today that Thomas B. King has been appointed to VIVUS' board of directors. Mr. King's nearly 40 year...

VIVUS Settlement Could Clue In Orexigen Investors

  Life Sciences Jobs   ...

VIVUS Announces Settlement With Actavis On Qsymia Patent Litigation

  Life Sciences Jobs   ...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Muse [VIVUS, Inc.]

MUSE(alprostadil) urethral suppository

Muse [Meda Pharmaceuticals Inc.]

MUSE (alprostadil) suppository[VIVUS, Inc.]

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Multi-Center Study to Evaluate Estradiol Transdermal Spray in the Treatment of Symptomatic Postmenopausal Women

Estradiol treatment is effective at reducing vasomotor symptoms (eg, hot flushes) in postmenopausal women. Vivus has a proprietary spray delivery system (Evamist) for estradiol. This stu...

Companies [3 Associated Companies listed on BioPortfolio]

VIVUS, Inc.

VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed p...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the pot...

Aventyn, Inc.

Aventyn is the first company to deliver innovative secure connected information processing solutions with its standards based CLIP® solution to efficiently manage health inform...

More Information about "Vivus" on BioPortfolio

We have published hundreds of Vivus news stories on BioPortfolio along with dozens of Vivus Clinical Trials and PubMed Articles about Vivus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vivus Companies in our database. You can also find out about relevant Vivus Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record